Arcutis Biotherapeutics Statistics
Total Valuation
ARQT has a market cap or net worth of $1.75 billion. The enterprise value is $1.63 billion.
Important Dates
The next confirmed earnings date is Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ARQT has 118.64 million shares outstanding. The number of shares has increased by 74.53% in one year.
| Current Share Class | 118.64M |
| Shares Outstanding | 118.64M |
| Shares Change (YoY) | +74.53% |
| Shares Change (QoQ) | +0.50% |
| Owned by Insiders (%) | 1.89% |
| Owned by Institutions (%) | 84.51% |
| Float | 85.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.06 |
| Forward PS | 5.67 |
| PB Ratio | 11.01 |
| P/TBV Ratio | 11.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.15, with a Debt / Equity ratio of 0.70.
| Current Ratio | 4.15 |
| Quick Ratio | 3.72 |
| Debt / Equity | 0.70 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.73 |
Financial Efficiency
Return on equity (ROE) is -113.76% and return on invested capital (ROIC) is -28.52%.
| Return on Equity (ROE) | -113.76% |
| Return on Assets (ROA) | -23.25% |
| Return on Invested Capital (ROIC) | -28.52% |
| Return on Capital Employed (ROCE) | -47.93% |
| Revenue Per Employee | $574,684 |
| Profits Per Employee | -$409,471 |
| Employee Count | 342 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 1.38 |
Taxes
In the past 12 months, ARQT has paid $647,000 in taxes.
| Income Tax | 647,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +68.42% in the last 52 weeks. The beta is 1.68, so ARQT's price volatility has been higher than the market average.
| Beta (5Y) | 1.68 |
| 52-Week Price Change | +68.42% |
| 50-Day Moving Average | 14.39 |
| 200-Day Moving Average | 11.84 |
| Relative Strength Index (RSI) | 52.93 |
| Average Volume (20 Days) | 2,526,164 |
Short Selling Information
The latest short interest is 14.63 million, so 12.33% of the outstanding shares have been sold short.
| Short Interest | 14.63M |
| Short Previous Month | 15.11M |
| Short % of Shares Out | 12.33% |
| Short % of Float | 17.16% |
| Short Ratio (days to cover) | 5.61 |
Income Statement
In the last 12 months, ARQT had revenue of $196.54 million and -$140.04 million in losses. Loss per share was -$1.16.
| Revenue | 196.54M |
| Gross Profit | 177.41M |
| Operating Income | -128.40M |
| Pretax Income | -214.05M |
| Net Income | -140.04M |
| EBITDA | -125.80M |
| EBIT | -128.40M |
| Loss Per Share | -$1.16 |
Full Income StatementBalance Sheet
The company has $227.96 million in cash and $110.59 million in debt, giving a net cash position of $117.37 million or $0.99 per share.
| Cash & Cash Equivalents | 227.96M |
| Total Debt | 110.59M |
| Net Cash | 117.37M |
| Net Cash Per Share | $0.99 |
| Equity (Book Value) | 157.54M |
| Book Value Per Share | 1.34 |
| Working Capital | 254.81M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$112.16 million and capital expenditures -$143,000, giving a free cash flow of -$112.30 million.
| Operating Cash Flow | -112.16M |
| Capital Expenditures | -143,000 |
| Free Cash Flow | -112.30M |
| FCF Per Share | -$0.95 |
Full Cash Flow StatementMargins
Gross margin is 90.27%, with operating and profit margins of -65.33% and -71.25%.
| Gross Margin | 90.27% |
| Operating Margin | -65.33% |
| Pretax Margin | -70.92% |
| Profit Margin | -71.25% |
| EBITDA Margin | -64.01% |
| EBIT Margin | -65.33% |
| FCF Margin | n/a |
Dividends & Yields
ARQT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -74.53% |
| Shareholder Yield | -74.53% |
| Earnings Yield | -8.02% |
| FCF Yield | -6.43% |
Analyst Forecast
The average price target for ARQT is $18.80, which is 27.72% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $18.80 |
| Price Target Difference | 27.72% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 34.35% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ARQT has an Altman Z-Score of -0.93 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.93 |
| Piotroski F-Score | 3 |